In Brief: Canadian Bill C-91
This article was originally published in The Tan Sheet
Executive Summary
Canadian Bill C-91: Parliamentary Committee on Industry review of Bill C-91, an act that would establish a Patented Medicine Prices Review Board to set price controls for patented drugs, has been tabled. The Nonprescription Drug Manufacturers Association of Canada had requested that nonprescription drugs be excluded from the act in a March 27 brief ("The Tan Sheet" April 21, p. 11)...